Resources
A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.
View allHey there! Welcome!
Get updated on
Select Speciality
Key Trials
Sitagliptin-Based Triple FDC Outperforms Metformin + High-Dose Glimepiride
India’s first large-scale study showed that the sitagliptin/metformin/glimepiride triple FDC delivered superior HbA1c reduction at 16 weeks vs. metformin plus high-dose glimepiride, was well tolerated, & may reduce pill burden to support adherence.
Spotlight
Slide Library
Pulmonologists’ Perspectives and Practice Patterns in India on the Diagnosis and Treatment of PH
This presentation summarizes the key findings based on pulmonologists’ perspectives from a survey conducted to understand clinicians perspectives and practice patterns in both the diagnosis and treatment of group 1 and group 3 PH, which can further help optimize the management of PH patients.
Patient Education
View all
